Zhengkang Qiao
Overview
Explore the profile of Zhengkang Qiao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu Y, Li J, Li S, Yang Z, Qiao Z, Gu X, et al.
Cell Commun Signal
. 2024 Aug;
22(1):407.
PMID: 39164737
Dysregulation of splicing factor expression plays a crucial role in the progression of hepatocellular carcinoma (HCC). Our research found that the expression level of splicing factor ZMAT2 was increased in...
2.
Li J, Wang W, Li S, Qiao Z, Jiang H, Chang X, et al.
Cancer Cell Int
. 2024 May;
24(1):176.
PMID: 38769521
Background: Hepatocellular carcinoma (HCC) represents one of the most significant causes of mortality due to cancer-related deaths. It has been previously reported that the TGF-β signaling pathway may be associated...
3.
Zhao N, Wang W, Jiang H, Qiao Z, Sun S, Wei Y, et al.
Anticancer Agents Med Chem
. 2023 Apr;
23(13):1506-1518.
PMID: 37026490
Gastric cancer is a severe malignant tumor with high morbidity and mortality, which seriously affects people's health. At present, the most common treatment for gastric cancer is chemotherapy. However, chemotherapy...
4.
Yang C, Wang W, Li S, Qiao Z, Ma X, Yang M, et al.
Front Immunol
. 2023 Mar;
14:1113385.
PMID: 36960059
Instruction: Ulcerative colitis (UC) can cause a variety of immune-mediated intestinal dysfunctions and is a significant model of inflammatory bowel disease (IBD). Colorectal cancer (CRC) mostly occurs in patients with...